Clinical Trial

Iron Absorption From Plant Heme Iron

Study acronym: PHIA
Completed
View on ClinicalTrials.gov →
Summary
Heme, an iron protoporphyin IX complex, consists of a ferrous ion captured in a porphyrin ring acting as a tetradentate ligand. The unique features of heme iron -its unusually high absorption in foods and its resistance to luminal inhibitors of iron absorption- make it a potentially interesting iron fortificant. This study aims to compare fractional iron absorption from two plant-derived heme iron compounds-iron chlorophyllin and soy hemoglobin-with ferrous sulfate (negative control) and porcine hemoglobin (positive control) in iron-deficient women. All four compounds will be intrinsically labeled with stable iron isotopes. Fractional absorption will be assessed 14 days after test meal administration via erythrocyte iron incorporation. Absorption will be tested in two matrices: water and maize porridge (an inhibitory matrix). Each participant will consume all test conditions in a randomized order, allowing for within-subject comparisons.
Protocol Amendment History 2 changes
critical Trial completed 2026-06-03
critical Primary endpoint(s) modified 2026-06-03
Trial Details
NCT Number NCT07143890
Lead Sponsor ETH Zurich
Conditions Iron Deficiency (ID), Iron Absorption
Enrollment 45 participants
Start Date 2025-09-22
Primary Completion 2026-05-26 (estimated)
Study Completion 2026-05-26 (estimated)
Updated on ClinicalTrials.gov 2026-06-02